We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+15.58%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$277M
AUM Growth
-$184M
Cap. Flow
-$202M
Cap. Flow %
-73.1%
Top 10 Hldgs %
50.24%
Holding
173
New
45
Increased
19
Reduced
28
Closed
52

Top Buys

Rank Stock Value
1
VPHM
VIROPHARMA INC
VPHM
+$21.5M
2
SNTS
SANTARUS INC
SNTS
+$11.3M
3
LSI
LSI CORPORATION
LSI
+$10.4M
4
GYRO icon
Gyrodyne
GYRO
+$6.54M
5
RDA
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
+$5.07M

Top Sells

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$38.1M
2
NYX
NYSE EURONEXT INC
NYX
+$33.5M
3
DELL
DELL INC
DELL
+$29.1M
4
FIRE
SOURCEFIRE INC COM STK
FIRE
+$15.4M
5
SKS
SAKS INCORPORATED
SKS
+$15M

Sector Composition

Rank Sector Weight
1 Communication Services 9.52%
2 Healthcare 5.72%
3 Technology 5.47%
4 Consumer Discretionary 5.15%
5 Financials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPTR
151
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
– –
-796,617
Closed -$10M
WMS
152
DELISTED
WMS INDS INC
WMS
– –
-339,480
Closed -$8.81M
KDN
153
DELISTED
KAYDON CORP
KDN
– –
-84,363
Closed -$3M
TMS
154
DELISTED
TMS INTERNATIONAL CORP CLASS A COM STK
TMS
– –
-64,121
Closed -$1.12M
BKR
155
DELISTED
BAKER MICHAEL CORP
BKR
– –
-114,878
Closed -$4.65M
ASTX
156
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
– –
-345,809
Closed -$2.94M
RUE
157
DELISTED
RUE21 INC COM STK (DE)
RUE
– –
-11,590
Closed -$467K
FIRE
158
DELISTED
SOURCEFIRE INC COM STK
FIRE
– –
-202,687
Closed -$15.4M
MFB
159
DELISTED
MAIDENFORM BRANDS, INC
MFB
– –
-105,432
Closed -$2.48M
VHS
160
DELISTED
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
– –
-413,813
Closed -$8.69M
ONXX
161
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
– –
-305,170
Closed -$38.1M
VLTR
162
DELISTED
VOLTERRA SEMCONDUCTOR CORP
VLTR
– –
-463,536
Closed -$10.7M
CLP
163
DELISTED
COLONIAL PROPERTIES TRUST
CLP
– –
-23,800
Closed -$535K
MAXY
164
DELISTED
MAXYGEN INC
MAXY
– –
-616,854
Closed -$31K
MOLXA
165
DELISTED
MOLEX INC CL-A
MOLXA
– –
-342,785
Closed -$13.1M
MWW
166
DELISTED
Monster Worldwide Inc
MWW
– –
-390,041
Closed -$1.72M
MPG
167
DELISTED
MPG OFFICE TRUST, INC COM
MPG
– –
-60,047
Closed -$188K
STL
168
DELISTED
STERLING BANCORP
STL
– –
-100,199
Closed -$1.38M
VRNM
169
DELISTED
VERENIUM CORP COM STK (US)
VRNM
– –
-169,268
Closed -$672K
3 4 5 6
7

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, Gabelli & Co Investment Advisers held 173 positions worth $277M, down 40% from $461M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $202M in Q4 2013, closing 52 positions and reducing 28 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $38.1M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.5% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in VIROPHARMA INC worth $23.9M.

  • Gabelli & Co Investment Advisers's largest Q4 2013 buy was VIROPHARMA INC: 479,941 shares worth $23.9M.
  • Gabelli & Co Investment Advisers added most to Gyrodyne in Q4 2013, an estimated $6.54M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2013 reduction was Vodafone, cutting an estimated $4.46M.
  • Gabelli & Co Investment Advisers fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $38.1M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 50% of its $277M portfolio in Q4 2013.
  • Gabelli & Co Investment Advisers opened 45 new positions and closed 52 in Q4 2013.
  • Gabelli & Co Investment Advisers's portfolio value fell 40% quarter-over-quarter to $277M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2013, filed 7 Feb 2014.